Association of renal injury with nitric oxide deficiency in aged SHR: Prevention by hypertension control with AT1 blockade

Kidney International

Volumn 62, Issue 3, 2002, Pages 914-921

  Zhou, Xin Joseph ^a,b   Vaziri, Nosratola D ^a,b   Zhang, Jianwei ^a,b   Wang, Hong W ^a,b   Wang, Xiu Q ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pressure; Endstage renal disease; Essential hypertension; Losartan; Nitric oxide synthase; Nitrotyrosine; Spontaneously hypertensive rats

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENZYME DEFICIENCY; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HISTOLOGY; HISTOPATHOLOGY; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEINURIA; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; URINARY EXCRETION;

EID: 0036422702     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00516.x     Document Type: Article

References (43)

1. Blyth WB, Maddux FW: Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis 18:33-37, 1991
2. US Renal Data Systems: 1995 Annual Data Report. National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases, III: Incidence and causes of treated ESRD. Am J Kidney Dis 26(Suppl):S39-S50, 1995
3. National High Blood Pressure Education Program: National high blood pressure education program group report on hypertension and chronic renal failure. Arch Intern Med 151:12801287, 1991
4. Innes A, Johnston P J, Morgan AG, et al: Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Quart J Med 86:271-275, 1993
5. Frolich ED: Influence of nitric oxide and angiotensin II on renal involvement in hypertension. Hypertension 29:188-193, 1997
6. Feld LB, Van Liew JB, Galaske RG, Boylan JW: Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat. Kidney Int 12:332-343, 1977
7. Feld LG, Cacchero S, Van Liew JB, et al: Enalapril and renal injury in spontaneously hypertensive rats. Hypertension 16:544-554, 1990
8. Komatsu K, Frohlich ED, Ono H, et al: Glomerular dynamics and morphology of aged SHR. Hypertension 25:207-213, 1995
9. Kane BC: Localization of nitric oxide synthase isoforms in the kidney. Semin Nephrol 19:230, 1999
10. Garg UC, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 257:F60-F66, 1989
11. Trachtman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207:120-125, 1995
12. Vaziri ND, Ni Z, Oveisi F: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31:1248-1254, 1998
13. Akiba Y, Yamaguchi N, Amano H, et al: Role of nitric oxide in control of blood pressure in young and adult spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22(Suppl 1):S142-S143, 1995
14. Tomita T, Onda T, Mashiko S, et al: Blood pressure-related changes of endothelium-dependent relaxation in the aorta from SHRSP at developmental ages of hypertension. Clin Exp Pharmacol Physiol 22(Suppl 1):S139-S141, 1995
15. Gil-Longo J, Fernandez-Grandal D, Alvarez M, et al: Study of in vivo and in vitro resting vasodilator nitric oxide tone in normotensive and genetically hypertensive rats. Eur J Pharmacol 310:175-183, 1996
16. Wu CC, Hong HJ, Chou TC, et al: Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats. Biochem Biophys Res Commun 228:459-466, 1996
17. Hayakawa H, Raij L: Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31:266-270, 1998
18. Cuevas P, Garcia-calvo M, Carceller F, et al: Correction of hypertension by normalization of endothelial level of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc Natl Acad Sci USA 93:11996-12001, 1996
19. Chou T, Yen M, Li C, Dine Y: Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643-648, 1998
20. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32:59-64, 1998
21. Vaziri ND, Ni Z, Tarnavsky-Hobbs DL: Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36:957-964, 2000
22. Ma XL, Gao F, Nelson AH, et al: Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J Pharmacol Exp Ther 298:879-885, 2001
23. Eiserich JP, Butler J, Van Der Vliet A, et al: Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J 310:745749, 1995
24. Bataineh A, Raij L: Angiotensin II, nitric oxide, and end-organ damage in hypertension. Kidney Int 54(Suppl 68):S14-S19, 1998
25. Kaneko K, Susic D, Nunez E, Frohlich ED: Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J Hypertens 14:645-653, 1996
26. Vaziri ND, Ni Z, Wang XQ, et al: Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am J Physiol 274:F642-F649, 1998
27. Zhou XJ, Lasik Z, Ni Z, et al: Downregulation of renal endothelial nitric oxide synthase expression in experimental thrombotic microangiopathy. Lab Invest 80:1079-1087, 2000
28. Zhou XJ, Laszik Z, Wang XQ, et al: Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 80:1905-1914, 2000
29. Zhou XJ, Vaziri ND, Wang XQ, et al: Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 300:762-767, 2002
30. Dubois G: Decreased L-arginine-nitric oxide pathway in cultured myoblasts from spontaneously hypertensive versus normotensive Wistar-Kyoto rats. FEBS Lett 392:222-224, 1996
31. Malinsky T, Kapturczak M, Dayharsh J, Bohr D: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194:654-658, 1993
32. Crabos M, Cost P, Paccalin M, et al: Reduced basal NO-mediated dilation and decreased NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 29:55-65, 1997
33. Sunano S, Li-Bo Z, Matsuda K, et al: Endothelium-dependent relaxation by alpha 2-adrenoreceptor agonists in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 27:733-739, 1996
34. Eiserich JP, Hristova M, Cross CE, et al: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophlis. Nature 391:393-397, 1998
35. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxinitrite: The good, bad, and ugly. Am J Physiol 271:C1424-C1437, 1996
36. Vaziri ND, Liang K, Ding Y: Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56:1492-1498, 1999
37. Vaziri ND, Ni Z, Oveisi F, et al: Enhanced NO inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertens 39:135-141, 2002
38. Ushio-Fukai M, Zafari AM, Fukui T, et al: p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321, 1996
39. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
40. Hishikawa K, Oemar BS, Yang Z, Luscher TF: Pulsatile stretch stimulates superoxide production and activates nuclear factorkappa B in human coronary smooth muscle. Circ Res 81:797803, 1997
41. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324-F337, 1985
42. Ono H, Ono Y, Frohlich ED: Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal and glomerular hemodynamics. Hypertension 26:249-255, 1995
43. Miyoshi A, Suzuki H, Fujiwara M, et al: Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 10:1083-1090, 1997